Congratulations
CONGRATULATIONS to Dr. Leibold for receiving funding for a new R01 HL168492 entitled “Cell Cycle Regulation of IRP2 Phosphorylation During Hematopoeisis.”
Preliminary data for this proposal were supported by a Pilot and Feasibility grant from the University of Utah Center of Excellence in Hematology (CIHD) and the Mutation, Generation, Detection Core and the Iron and Heme Core.
Elizabeth A Leibold, PhD
Professor, Division of Hematology and Hematologic Malignancies,
Department of Internal Medicine
University of Utah School of Medicine
